Eric P Thelin1, David W Nelson, Bo-Michael Bellander. 1. Department of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Karolinska University Hospital Solna, R2:02, 171 76, Stockholm, Sweden, eric.thelin@ki.se.
Abstract
INTRODUCTION: Patients suffering from severe traumatic brain injury (TBI) often develop secondary brain lesions that may worsen outcome. S100B, a biomarker of brain damage, has been shown to increase in response to secondary cerebral deterioration. The aim of this study was to analyze the occurrence of secondary increases in serum levels of S100B and their relation to potential subsequent radiological pathology present on CT/MRI-scans. METHODS: Retrospective study from a trauma level 1 hospital, neuro-intensive care unit. 250 patients suffering from TBI were included. Inclusion required a minimum of two radiological examinations and at least three serum samples of S100B, with at least one >48 h after trauma. RESULTS: Secondary pathological findings on CT/MRI, present in 39 % (n = 98) of the patients, were highly correlated to secondary increases of ≥0.05 μg/L S100B (P < 0.0001, pseudo-R (2) 0.532). Significance remained also after adjusting for known important TBI predictors. In addition, secondary radiological findings were significantly correlated to outcome (Glasgow Outcome Score, GOS) in uni-(P < 0.0001, pseudo-R (2) 0.111) and multivariate analysis. The sensitivity and specificity of detecting later secondary radiological findings was investigated at three S100B cut-off levels: 0.05, 0.1, and 0.5 μg/L. A secondary increase of ≥0.05 μg/L had higher sensitivity (80 %) but lower specificity (89 %), compared with a secondary increase of ≥0.5 μg/L (16 % sensitivity, 98 % specificity), to detect secondary radiological findings. CONCLUSIONS: Secondary increases in serum levels of S100B, even as low as ≥0.05 μg/L, beyond 48 h after TBI are strongly correlated to the development of clinically significant secondary radiological findings.
INTRODUCTION:Patients suffering from severe traumatic brain injury (TBI) often develop secondary brain lesions that may worsen outcome. S100B, a biomarker of brain damage, has been shown to increase in response to secondary cerebral deterioration. The aim of this study was to analyze the occurrence of secondary increases in serum levels of S100B and their relation to potential subsequent radiological pathology present on CT/MRI-scans. METHODS: Retrospective study from a trauma level 1 hospital, neuro-intensive care unit. 250 patients suffering from TBI were included. Inclusion required a minimum of two radiological examinations and at least three serum samples of S100B, with at least one >48 h after trauma. RESULTS: Secondary pathological findings on CT/MRI, present in 39 % (n = 98) of the patients, were highly correlated to secondary increases of ≥0.05 μg/L S100B (P < 0.0001, pseudo-R (2) 0.532). Significance remained also after adjusting for known important TBI predictors. In addition, secondary radiological findings were significantly correlated to outcome (Glasgow Outcome Score, GOS) in uni-(P < 0.0001, pseudo-R (2) 0.111) and multivariate analysis. The sensitivity and specificity of detecting later secondary radiological findings was investigated at three S100B cut-off levels: 0.05, 0.1, and 0.5 μg/L. A secondary increase of ≥0.05 μg/L had higher sensitivity (80 %) but lower specificity (89 %), compared with a secondary increase of ≥0.5 μg/L (16 % sensitivity, 98 % specificity), to detect secondary radiological findings. CONCLUSIONS: Secondary increases in serum levels of S100B, even as low as ≥0.05 μg/L, beyond 48 h after TBI are strongly correlated to the development of clinically significant secondary radiological findings.
Authors: Peter Biberthaler; Ulrich Linsenmeier; Klaus-Juergen Pfeifer; Michael Kroetz; Thomas Mussack; Karl-Georg Kanz; Eduard F J Hoecherl; Felix Jonas; Ingo Marzi; Phillip Leucht; Marianne Jochum; Wolf Mutschler Journal: Shock Date: 2006-05 Impact factor: 3.454
Authors: M Kapural; Lj Krizanac-Bengez; G Barnett; J Perl; T Masaryk; D Apollo; P Rasmussen; M R Mayberg; D Janigro Journal: Brain Res Date: 2002-06-14 Impact factor: 3.252
Authors: D I Graham; I Ford; J H Adams; D Doyle; G M Teasdale; A E Lawrence; D R McLellan Journal: J Neurol Neurosurg Psychiatry Date: 1989-03 Impact factor: 10.154
Authors: Camilo Toro; Sonia Jain; Shelly Sun; Nancy Temkin; Jason Barber; Geoffrey Manley; Jordan M Komisarow; Tetsu Ohnuma; Brandon Foreman; Frederick Korley; Michael L James; Daniel Laskowitz; Monica S Vavilala; Adrian Hernandez; Joseph P Mathew; Amy J Markowitz; Vijay Krishnamoorthy Journal: J Neurosurg Anesthesiol Date: 2021-12-30 Impact factor: 3.969
Authors: Faiez Al Nimer; Eric Thelin; Harriet Nyström; Ann M Dring; Anders Svenningsson; Fredrik Piehl; David W Nelson; Bo-Michael Bellander Journal: PLoS One Date: 2015-07-02 Impact factor: 3.240